leukemia, myeloid, acute

Showing 1 - 25 of 163

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Myeloid, Acute Trial in Guangzhou, Hangzhou (BG1805)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • BG1805
  • Guangzhou, Guangdong, China
  • +2 more
Nov 1, 2023

AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

Not yet recruiting
  • AML
  • +11 more
  • (no location specified)
Aug 14, 2023

Leukemia, Myeloid, Acute Trial in United States (VCAR33)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • VCAR33
  • La Jolla, California
  • +9 more
Aug 14, 2023

Stem Cell Transplantation, MDS, Leukemia, Myeloid, Acute Trial in Miami (Mindfulness-based Music Therapy (MBMT), Mindfulness

Not yet recruiting
  • Stem Cell Transplantation
  • +4 more
  • Mindfulness-based Music Therapy (MBMT)
  • Mindfulness Meditation (MM)
  • Miami, Florida
    University of Miami
Aug 1, 2023

Leukemia, Myeloid, Acute Trial (CD33KO-HSPC; CART33)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • CD33KO-HSPC; CART33
  • (no location specified)
Jul 13, 2023

MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

Not yet recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Subcutaneous azacitidine
  • Oral decitabine/cedazuridine
  • Newcastle, New South Wales, Australia
    Calvary Mater Newcastle
May 29, 2023

Mold Infections in Children During Leukemia Treatment

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Acute Lymphoblastic Leukemia
    • Odense, Denmark
      Rasmus Møller Duus
    Mar 7, 2023

    Novel Digital Array PCR for Acute Myeloid Leukemia (AML)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Minimal Residual Disease
      • Chapel Hill, North Carolina
        North Carolina Cancer Hospital (NCCH)
      Feb 2, 2023

      Leukemia, Myeloid, Acute Trial in Poznan (Liposomal Annamycin, Cytarabine)

      Recruiting
      • Leukemia, Myeloid, Acute
      • Bologna, Italy
      • +4 more
      Jan 31, 2023

      Leukemia, Myeloid, Acute Trial in Canada, United States (VOR33, Mylotarg)

      Recruiting
      • Leukemia, Myeloid, Acute
      • La Jolla, California
      • +8 more
      Jan 31, 2023

      Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)

      Active, not recruiting
      • Leukemia
      • +7 more
      • Boston, Massachusetts
      • +10 more
      Jan 19, 2023

      Leukemia, Myeloid, Acute Trial in Worldwide (Oral Azacitidine, Placebo)

      Active, not recruiting
      • Leukemia, Myeloid, Acute
      • Oral Azacitidine
      • Placebo
      • Phoenix, Arizona
      • +247 more
      Jan 13, 2023

      Leukemia, Myeloid, Acute Trial in Chengdu (Chidamide)

      Recruiting
      • Leukemia, Myeloid, Acute
      • Chengdu, Sichuan, China
        West China Hospital of Sichuan University
      Dec 27, 2022

      Leukemia, Myeloid, Acute Trial in China (CC-486, Placebo)

      Recruiting
      • Leukemia, Myeloid, Acute
      • Hefei, Anhui, China
      • +31 more
      Jan 10, 2023

      Leukemia, Myeloid, Acute Trial in Worldwide (CC-90009, Venetoclax, Azacitidine)

      Recruiting
      • Leukemia, Myeloid, Acute
      • San Francisco, California
      • +25 more
      Jan 9, 2023

      Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine, Cusatuzumab)

      Active, not recruiting
      • Leukemia, Myeloid, Acute
      • Darlinghurst, Australia
      • +55 more
      Dec 28, 2022

      Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Miami (Total Body Irradiation (TBI), Thiotepa, Cyclophosphamide)

      Not yet recruiting
      • Leukemia, Myeloid, Acute
      • Leukemia, Lymphocytic, Acute
      • Total Body Irradiation (TBI)
      • +5 more
      • Miami, Florida
        Baptist Health South Florida/Miami Cancer Institute
      Nov 28, 2022

      Leukemia, Myeloid, Acute Trial (Cytarabine, Venetoclax, CPX-351)

      Not yet recruiting
      • Leukemia, Myeloid, Acute
      • (no location specified)
      Nov 25, 2022

      Leukemia, Myeloid, Acute, AML Stage, Adult Trial in Xiamen (Venetoclax Combining Chidamide and Azacitidine (VCA) regimen

      Not yet recruiting
      • Leukemia, Myeloid, Acute
      • AML Stage, Adult
      • Venetoclax Combining Chidamide and Azacitidine (VCA) regimen followed by dicitabine combined with liposome mitoxantrone, cytarabine, and G-CSF (D-MAG) regimen
      • Xiamen, Fujian, China
        Bing Xu
      Oct 29, 2022

      Leukemia, Myeloid, Acute Trial in Jerusalem (Vyxeos, Mylotarg)

      Recruiting
      • Leukemia, Myeloid, Acute
      • Jerusalem, Yerushalayim, Israel
        Shaare Zedek Medical Center
      Oct 25, 2022

      Leukemia, Myeloid, Acute, Leukemia, B-cell, Leukemia, T Cell Trial in Monza (Sport Therapy)

      Recruiting
      • Leukemia, Myeloid, Acute
      • +7 more
      • Sport Therapy
      • Monza, MB, Italy
        Maria Letizia Verga Center, Pediatric Clinic, University of Mila
      Oct 24, 2022

      Leukemia, Myeloid, Acute, MDS, Hematopoietic Stem Cell Transplantation Trial in Shanghai (Venetoclax plus RIC)

      Not yet recruiting
      • Leukemia, Myeloid, Acute
      • +3 more
      • Venetoclax plus RIC
      • Shanghai, Shanghai, China
        Shanghai General Hospital
      Oct 12, 2022

      Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

      Recruiting
      • Leukemia
      • +19 more
      • CYNK-001
      • Denver, Colorado
      • +9 more
      Sep 9, 2022